1[1]Reiter RJ,Melchiorri D,Sewerynek E,et al. A review of the evidence sup porting melatonin s role as an antioxident[J]. J Pineal R es, 1995,18: 1 11.
3[3]Pablos MI,Chuang J,Reiter RJ,et al. Time course of the melatonin-induced increase in glutathione peroxidase activity in chick tissues [J]. Bilo Signals,1996,4(6) : 325-330.
4[4]Gilad ES,Cuzzocrea B,Zingarelli AL. et al. Melatonin is a scavenger of per oxinitrite[J]. Life Sci,1997,60:1169-1174.
6[6]Chen LD,Tan DX,Reiter RJ,et al. In vivo and in vitro effects of the pineal gland and melatonin on [Ca2+ +Mg2+ ] dependent ATPase in cardiac sar colemma[J]. J Pineal Res, 1993,14 : 178-183.
7[7]Sandkyk R,Awerbuch GI. The relationship between melatonin secretion and serum cholestrol in patients with multiplesclerosis [J ]. Int J Neurosci, 1994,76(1/2): 81-86.
8[8]Kawashima K,Miwa Y,Fujimoto K,et al. Antihypertensive action of mela tonin in the spontaneously hypertensive rat [J]. Clin Exp Hypertern, 1987,A9:1121-1131.
9[9]Birau N, Peterssen U, Meyer C, et al. Hypotensive effect of melatonin i nessential hypertension[J]. IRCS Med Sci, 1981,9: 906-909.
10[10]Tang PL,Pang SF,Reiter RJ,eds. Melatonin:A universal photoperiodic signal with diverse action[M]. Basel: Karger, 1996,208
3ANTOHE F. Endothelial cells and macrophages, partners in atherosclerotic plaque progression[J]. Arch Physiol Biochem, 2006,112(4):245-253.
4LIBBY P, AIKAWA M, JAIN M K. Vascular endothelium and atherosclerosis[J] .Handb Exp Pharmacol,2006, (176 Pt 2):285-306.
5LIOU S F, YEH J L, LIANG J C, et al. Inhibition of mitogen-mediated proliferation of rat vascular smooth muscle cells by labedipinedilol-A through PKC and ERK 1/2 pathway[J] 9r Cardiovasc Pharmacol, 2004,44(5):539-551.
6GIROTTI L, LAGO M, IANOVSKY O, et al. Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease[J]. JPinealRes, 2000,29(3):138-142.
7SAKOTNIK A, LIEBMANN P M, STOSCHITZKY K, et al. Decreased melatonin synthesis in patients with coronary artery disease[J] .Eur Heart J, 1999,20( 18): 1314-1317.
8SEWWRYNEK E. Melatonin and the cardiovascular system[J]. Neuro Endocrinol Lett,2002,23( Suppl 1 ): 79-83.
9ZHU H Q, CHENG X W, XIAO L Let al. Melatonin prevents oxidized low-density lipoprotein-induced increase of myosin light chain kinase activation and expression in HUVEC through ERK/MAPK signal transduction[J].J Pineal Res,2008, 45 (3): 328-334.
10CHEN Y, LEE M Y, CHEN H Y, et al. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice[J]. J Pineal Res, 2006,40(3):242-250.
